There is very little published information about Liftera, and we are not going to guess. We could not establish who makes it, whether it holds a US clearance, what any clearance covers, what depths its transducers focus at, or whether any trial of it has been published. That is a statement about what we could verify, not an accusation. It should shape the questions you ask a clinic, and it is the honest starting point for this comparison.
Ultherapy's record can be read line by line. It was granted through a De Novo request (DEN080006, 11 September 2009), which created its FDA device category outright. Its current cleared wording is to lift the eyebrow, lift lax submental and neck tissue, and improve lines and wrinkles of the décolleté. A February 2025 clearance (K243035) added skin laxity on the abdomen and the front and back of the arms.
Focused ultrasound devices are not interchangeable, even when the marketing sounds identical. Machines in this space differ on three things that matter: how deep the transducers focus, what cartridges exist and how they are replaced, and whether the operator can see the tissue plane before firing. Ultherapy's imaging is cleared to visualise the dermal and subdermal layers up to 8 mm below the surface, so the operator can confirm the depth of treatment and avoid bone. Whether Liftera offers anything comparable is not something we can tell you.
And clearance is never proof of benefit. A De Novo grant, like a 510(k) clearance, is permission to market. It is not a finding that the treatment works. So the fair way to read this page is not "one works and one does not" - it is that for one device you can check the paperwork and for the other, at the time of writing, we could not.
Beyond that description, we could not verify the manufacturer, the model history or the US regulatory status.
Nothing breaks the skin.
Focused ultrasound in general concentrates acoustic energy at a point beneath the surface. Whether this device does that at the same depths, temperatures or pulse patterns is not something we could confirm.
At the focal point tissue reaches roughly 60 to 70 degrees Celsius, creating small columns of denatured collagen while the surface and everything above the focus are spared. Healing contracts and remodels those points over two to six months.
No transducer depths could be verified. This is the single most useful specification to ask a clinic for.
The 4.5 mm transducer reaches the superficial musculoaponeurotic layer, the SMAS.
We could not confirm a US clearance, so no indication text is quoted. This is not a claim that none exists.
Those are the cleared words as they stand today, consolidated in K180623 (2018) and extended by K243035 (February 2025). Ultherapy started as a De Novo grant in 2009 (DEN080006), but the exact wording of that 2009 document is not retrievable from the FDA archive, so it is not quoted here.
No labelled figure and no published study we could check.
This is the conventional clinical description, not a figure stated in the Indications for Use.
To be specific about the gap, so you can close it yourself:
None of this means the device does not work. It means that on the evidence available to this page, nothing can be said about how well it works, and nothing here should be read as either endorsement or warning.
Five questions, in order of usefulness:
Focused ultrasound is a family of treatments, not one treatment. A device focusing in the mid dermis and a device focusing at the SMAS are doing different jobs even though both are correctly described as focused ultrasound, and marketing language does not distinguish them.
That is why "which is better, Liftera or Ultherapy?" is not really answerable and, on the information available, not the right question. The answerable one is: at what depth is this machine working, who confirmed that depth, and what has been published about it?
If you get cold sores, tell your provider when you book, not on the day. Antiviral medicine is started in advance, so it has to be prescribed before the appointment. Neither of these treatments breaks the skin, and there is no published data on cold-sore reactivation after focused ultrasound specifically - the precaution is carried over from laser resurfacing, where reactivation is well documented. It is your provider's call to make, which is why they need to know beforehand.
Also tell them about any implants, injectable filler or previous surgery in the area to be treated.
Neither treatment breaks the skin, so infection is unlikely. If a burn or a blister does occur and then shows signs of spreading infection, that needs urgent care rather than a routine appointment: